Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DCVAC/LuCa + Chemotherapy in Stage IV NSCLC
NCT02470468Phase 2Completed
- Sponsor
- SOTIO Biotech
- Start
- Dec 2014
- Primary completion
- Jan 2018
- Modality
- Whole Cell Cancer Vaccines, Dendritic Cell Vaccines
- Countries
- 2
01
Overview
A Phase 2 trial of DCVAC/LuCa in non-small cell lung cancer (NSCLC), sponsored by SOTIO Biotech. Started Dec 2014; status: completed.
02
Drugs
DCVAC/LuCa
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT02470468.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02470468.